Glycopyrronium

CHEMBL1201335 Phase 4 Disetujui Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
318.4 g/mol
LogP
3.1
Phase
4

Used to treat chronic obstructive pulmonary disease (COPD), this medication works by relaxing the muscles around the airways in the lungs, making it easier to breathe. It is typically inhaled once daily to help keep the airways open throughout the day.

Berat Molekul

318,4000 g/mol

LogP

3,10

TPSA

46,50 Ų

Lipinski RO5

Lulus

Area Terapeutik

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Struktur 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

C[N+]1(C)CCC(OC(=O)C(O)(c2ccccc2)C2CCCC2)C1

InChI

InChI=1S/C19H28NO3/c1-20(2)13-12-17(14-20)23-18(21)19(22,16-10-6-7-11-16)15-8-4-3-5-9-15/h3-5,8-9,16-17,22H,6-7,10-14H2,1-2H3/q+1

Molecular Formula

C19H28NO3+

HBD / HBA

1 / 3

Ikatan yang Dapat Dirotasi

5

Atom Berat

23

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Pertanyaan yang Sering Diajukan

Used to treat chronic obstructive pulmonary disease (COPD), this medication works by relaxing the muscles around the airways in the lungs, making it easier to breathe. It is typically inhaled once daily to help keep the airways open throughout the day.

Yes, Glycopyrronium is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1201335. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 3494. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Penyangkalan Medis

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.